Responsive Document - CREW: FDA: Regarding Communications Between the FDA and Martin Shkreli:...

Preview:

Citation preview

  • 7/30/2019 Responsive Document - CREW: FDA: Regarding Communications Between the FDA and Martin Shkreli: 11/30/201

    1/12

  • 7/30/2019 Responsive Document - CREW: FDA: Regarding Communications Between the FDA and Martin Shkreli: 11/30/201

    2/12

  • 7/30/2019 Responsive Document - CREW: FDA: Regarding Communications Between the FDA and Martin Shkreli: 11/30/201

    3/12

  • 7/30/2019 Responsive Document - CREW: FDA: Regarding Communications Between the FDA and Martin Shkreli: 11/30/201

    4/12

  • 7/30/2019 Responsive Document - CREW: FDA: Regarding Communications Between the FDA and Martin Shkreli: 11/30/201

    5/12

  • 7/30/2019 Responsive Document - CREW: FDA: Regarding Communications Between the FDA and Martin Shkreli: 11/30/201

    6/12

  • 7/30/2019 Responsive Document - CREW: FDA: Regarding Communications Between the FDA and Martin Shkreli: 11/30/201

    7/12

  • 7/30/2019 Responsive Document - CREW: FDA: Regarding Communications Between the FDA and Martin Shkreli: 11/30/201

    8/12

  • 7/30/2019 Responsive Document - CREW: FDA: Regarding Communications Between the FDA and Martin Shkreli: 11/30/201

    9/12

  • 7/30/2019 Responsive Document - CREW: FDA: Regarding Communications Between the FDA and Martin Shkreli: 11/30/201

    10/12

  • 7/30/2019 Responsive Document - CREW: FDA: Regarding Communications Between the FDA and Martin Shkreli: 11/30/201

    11/12

  • 7/30/2019 Responsive Document - CREW: FDA: Regarding Communications Between the FDA and Martin Shkreli: 11/30/201

    12/12

Recommended